CORONAVIRUS/WHO selects Taiwan's Medigen COVID-19 vaccine for international trial
10/26/2021 10:46 PM
Taipei, Oct. 26 (CNA) A COVID-19 vaccine developed by Taiwan's Medigen Vaccine Biologics Corp. has been chosen to take part in an international clinical trial platform co-launched by the World Health Organization (WHO), according to a statement released by the organization Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
- Taiwan COVID-19 News Briefs: May 27Taiwan on Friday reported 94,855 new COVID-19 cases -- 94,808 domestic infections and 47 imported -- and a single-day high of 126 deaths from the disease, according to the ...05/27/2022 11:26 PM
- COVID to remain at 'high but stable plateau' for 2 weeks: health ministerHealth Minister Chen Shih-chung (陳時中) said Friday that the COVID-19 pandemic in Taiwan has started to plateau at a high but stable level that will last a minimum of two weeks.05/27/2022 09:27 PM
- Taiwan to offer free rapid COVID tests to children aged 6 or youngerFree COVID-19 rapid antigen tests will be provided to families with children aged six or younger, starting in June, according to the Central Epidemic Command Center (CECC) on ...05/27/2022 07:04 PM
Latest
- Politics
Taiwan signs LOI with financing bank to help Belizean economy
05/27/2022 11:32 PM - Society
Taiwan COVID-19 News Briefs: May 27
05/27/2022 11:26 PM - Society
Taiwan court says ruling on custody case over daughter unconstitutional
05/27/2022 11:14 PM - Business
Taipei introduces NT$2.85 billion COVID-19 bailout package
05/27/2022 10:41 PM - Business
New electricity rates for electric car owners to take effect May 30
05/27/2022 09:55 PM